StockMarketWire.com - JP Morgan Cazenove today reaffirms its neutral investment rating on Spire Healthcare Group [LON:SPI] and cut its price target to 127p (from 146p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk